[en] The baseline option for the very forward calorimetry in the CMS experiment is an iron/gas calorimeter based on parallel plate chambers. A small prototype module of such a calorimeter, has been tested using electrons of 5 to 100 GeV/c momentum with various high voltages and two gases: CO2 (100%) and CF4/CO2 (80/20), at atmospheric pressure. The collected charge has been measured as a function of the high voltage and of the electron energy. The energy resolution has also been measured. Comparisons have been made with Monte-Carlo predictions. Agreement between data an simulation allows to make and estimation of the expected performance of a full size calorimeter. (Author) 23 refs

[en] The baseline option for the very forward calorimetry in the CMS experiment is an iron/gas calorimeter based on parallel plate chambers. A small prototype module of such a calorimeter, has been tested using electrons of 5 to 100 GeV/c momentum with various high voltages and two gases: CO₂ (100%) and CF₄/CO₂(80/20), at atmospheric pressure. The collected charge has been measured as a function of the high voltage and of the electron energy. The energy resolution has also been measured. Comparisons have been made with Monte-Carlo predictions. Agreement between data an simulation allows to make and estimation of the expected performance of a full size calorimeter. (Author)

[en] To systematically review the role of positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). Methods. A comprehensive literature search of published studies regarding FDG-PET and PET/CT in patients with NF1 was performed. No beginning date limit and language restriction were used; the search was updated until December 2011. Only those studies or subsets in studies including whole-body FDG-PET or PET/CT scans performed in patients with NF1 were included. Results. We identified 12 studies including 352 NF1 patients. Qualitative evaluation was performed in about half of the studies and semiquantitative analysis, mainly based on different values of SUV cutoff, in the others. Most of the studies evaluated the role of FDG-PET for differentiating benign from malignant peripheral nerve sheath tumors (MPNSTs). Malignant lesions were detected with a sensitivity ranging between 100% and 89%, but with lower specificity, ranging between 100% and 72%. Moreover, FDG-PET seems to be an important imaging modality for predicting the progression to MPNST and the outcome in patients with MPNST. Two studies evaluated the role of FDG-PET in pediatric patients with NF1. Conclusions. FDG-PET and PET/CT are useful methods to identify malignant change in neurogenic tumors in NF1 and to discriminate malignant from benign neurogenic lesions

[en] The baseline option for the very forward calorimetry in the CMS experiment is an iron/gas calorimeter based on parallel plate chambers. A small prototype module of such a calorimeter, has been tested using electrons of 5 to 100 GeV/c momentum with various high voltages and two gases: CO₂ (100%) and CF₄/CO₂ (80/20), at atmospheric pressure. The collected charge has been measured as a function of the high voltage and of the electron energy. The energy resolution has also been measured. Comparisons have been made with Monte-Carlo predictions. Agreement between data and simulation allows to make an estimation of the expected performance of a full size calorimeter. (orig.)

[en] Present status of Parallel Plate Chambers (PPC) is reviewed. After a description of this detector, results from tests concerning PPC efficiency uniformity, radiation hardness, and behaviour in electromagnetic calorimetry are presented. Some possible utilizations in LHC experiments are mentioned. (orig.)